AzurBio Pharma
Empowering biopharmaceutical companies with a 1st life-changing medicine to expand to Europe.
Contact us
Europe. A fantastic opportunity for biopharmaceutical companies.
EU is the
2nd*
largest market globally
for prescription medicines
*23% Europe - Deloitte, 2023
Europe. A challenging and complex market to address.
Europe is Not a country
- Multiple regulatory and market access environments vs the US
- Market differences between individual European countries
Need Expertise and focused efforts to
- Understand Europe as a whole & as individual markets
- Adopting a strategic approach to market prioritization
Our Solutions.
We provide innovative solutions to enter the EU market by maximizing flexibility and minimizing operational burden, from registration through to commercialization.
Expand to Europe
A unique partnership model that goes beyond traditional full outsourcing or licensing agreements.
Available Soon
Available Soon
Available Soon
Available Soon
Unlock an EU country
Unlock France
Flexible Turnkey solutions to swiftly establish your locally compliant organization, surpassing conventional models.
Early Access Program
A unique, all-in-one solution for launching an early access program in one of Europe's most supportive regulatory environments
Our Clients. Innovators in rare or serious diseases.
AzurBio Pharma. The partner of choice for biopharmas.
- Paris (Headquarter)
- Nice
- Zug
- Boston
- New York